Update on the COVID-19 pandemic

Information regarding COVID-19 is in constant change, as is the situation regarding vaccination and prioritization for immune-compromised individuals.

If you have any COVID-19-related questions, we’ve created a specific COVID section on our website that can be accessed by clicking here or by selecting the “News & Events” tab from our homepage. In this section, you’ll find the latest news and information about the pandemic in Canada from trustworthy and reliable sources.

Any specific questions that you may have regarding the COVID-19 vaccination, delays between vaccine dosing, and prioritization within your province are best answered by your healthcare team. They’re the ones who know you and your particular situation and are therefore in a position to best address your unique concerns.

Created by, and entirely focused on, Canadians impacted by myeloma, Myeloma Canada is the only national charitable organization committed to providing you with the most up-to-date and reliable information on myeloma. Some of the ways we do this is through our monthly e-newsletter, “Myeloma Matters”, as well as through our social media platforms.

Please don’t hesitate to contact us at contact@myeloma.ca or toll-free at 1-888-798-5771 with any questions regarding our programs and services.


Make a donation

Summary of Clinical Trial Phases

Phase Number of Participants Goals
I 15 to 30 people
  • To find the safe maximum tolerated dose (MTD)
  • To decide how the treatment should be given (eg, orally or intravenously)?
  • To observe how the treatment affects the human body
II Less than 100 people
  • Uses the maximum tolerated dose (MTD) established during Phase I
  • To determine if the treatment has an effect on a particular stage of cancer
  • To see how the treatment affects the human body
III From 100 to 1,000 people
  • To compare a new agent or intervention (or new use of a treatment) with the current standard of care
IV Several hundred to several thousand people
  • To further evaluate the long-term safety and effectiveness of a new treatment in the “real world

Questions for your Healthcare Team

  • What kinds of therapies, procedures and/or tests will I have during the trial?
  • Will they hurt, and if so, for how long?
  • Will I be able to take my regular medications while in the clinical trial?
  • How do the tests in the study compare to those I would have outside of the trial?
  • Where will I have my medical care and who will be in charge of my care?